Xenetic Biosciences, Inc. (XBIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 3M 6M 9M Q4 '11: 13.7K Q1 '12: 36K Q2 '12: 36.4K Q3 '12: 26.6K Q4 '12: 33K Q1 '13: 32.6K Q2 '13: 39.4K Q2 '13: 1M Q3 '13: 8.6K Q3 '13: 0 Q4 '13: 2.2K Q4 '13: 0 Q1 '14: 0 Q1 '15: 0 Q3 '16: 0 Q4 '16: 3M Q3 '17: 85K Q4 '17: 7.5M Q3 '18: 0 Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 17.1K Q1 '20: 56.7K Q2 '20: 112.9K Q3 '20: 115.9K Q4 '20: 151.3K Q1 '21: 191.2K Q2 '21: 287.6K Q3 '21: 349.3K Q4 '21: 332.6K Q1 '22: 389K Q2 '22: 416.7K Q3 '22: 414.2K Q4 '22: 487K Q1 '23: 605.8K Q2 '23: 651K Q3 '23: 611.2K Q4 '23: 672K Q1 '24: 510.8K Q2 '24: 726.4K Q3 '24: 614.2K Q4 '24: 648.8K Q1 '25: 593.3K Q2 '25: 589.9K Q3 '25: 1M Q4 '25: 766.3K Q1 '26: 806.9K Q2 '26: 660.6K Q4 '11 Q2 '13 Q3 '16 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Gross Profit Quarterly

0 350K 700K 1.1M Q2 '12: 36.4K Q2 '13: 29.5K Q2 '13: 1M Q3 '13: 0 Q4 '13: 0 Q1 '14: 0 Q1 '15: 0 Q2 '12 Q2 '13 Q2 '13 Q3 '13 Q4 '13 Q1 '14 Q1 '15

Operating Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q4 '11: -14.8K Q1 '12: -26.1K Q2 '12: -35.6K Q3 '12: -40.1K Q4 '12: -11.3K Q1 '13: 18.2K Q1 '13: -1.4M Q2 '13: -10.3K Q2 '13: -1M Q3 '13: -62.2K Q3 '13: -2.5M Q4 '13: -76.8K Q4 '13: -3.5M Q1 '14: -3M Q2 '14: -2.6M Q3 '14: -3.1M Q4 '14: -4.2M Q1 '15: -2M Q2 '15: -1.4M Q3 '15: -3.8M Q4 '15: -2.7M Q1 '16: -1.9M Q2 '16: -43.3M Q3 '16: -2.3M Q4 '16: -64.4K Q1 '17: -2.9M Q2 '17: -2.9M Q3 '17: -2.2M Q4 '17: 4.4M Q1 '18: -1.8M Q2 '18: -2M Q3 '18: -1.8M Q4 '18: -1.6M Q1 '19: -1.3M Q2 '19: -1.4M Q3 '19: -8.9M Q4 '19: -1.2M Q1 '20: -1.2M Q2 '20: -982.5K Q3 '20: -10.5M Q4 '20: -1.2M Q1 '21: -1.4M Q2 '21: -1.1M Q3 '21: -1.4M Q4 '21: -1.9M Q1 '22: -1.6M Q2 '22: -2.7M Q3 '22: -847.8K Q4 '22: -1.6M Q1 '23: -915.2K Q2 '23: -1.2M Q3 '23: -1.1M Q4 '23: -1.3M Q1 '24: -1.3M Q2 '24: -1.3M Q3 '24: -499.5K Q4 '24: -1.1M Q1 '25: -942.4K Q2 '25: -724.4K Q3 '25: -544.7K Q4 '25: -623K Q1 '26: -502.1K Q2 '26: -971.7K Q1 '13 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q4 '11: -18.2K Q1 '12: -29.3K Q2 '12: -38.9K Q3 '12: -2.9K Q4 '12: -14.5K Q1 '13: 15.1K Q1 '13: -1.4M Q2 '13: -13.7K Q2 '13: -938.3K Q3 '13: -76.1K Q3 '13: -2.7M Q4 '13: -82.5K Q4 '13: -3.5M Q1 '14: -4.1M Q2 '14: -2.8M Q3 '14: -3.2M Q4 '14: -4.3M Q1 '15: -2.4M Q2 '15: -1.1M Q3 '15: -5.3M Q4 '15: -3.6M Q1 '16: -3.6M Q2 '16: -47.8M Q3 '16: -2.5M Q4 '16: -391.3K Q1 '17: -2.9M Q2 '17: -2.9M Q3 '17: -2.3M Q4 '17: 4.4M Q1 '18: -1.8M Q2 '18: -2M Q3 '18: -1.8M Q4 '18: -1.6M Q1 '19: -1.3M Q2 '19: -1.4M Q3 '19: -8.9M Q4 '19: -1.2M Q1 '20: -1.2M Q2 '20: -953.6K Q3 '20: -7.6M Q4 '20: -1.2M Q1 '21: -1.3M Q2 '21: -1.1M Q3 '21: -1.4M Q4 '21: -1.8M Q1 '22: -1.6M Q2 '22: -2.7M Q3 '22: -804K Q4 '22: -1.5M Q1 '23: -856.6K Q2 '23: -1.1M Q3 '23: -1.1M Q4 '23: -1.2M Q1 '24: -1.2M Q2 '24: -1.3M Q3 '24: -436.7K Q4 '24: -1.1M Q1 '25: -903.1K Q2 '25: -688.7K Q3 '25: -509.9K Q4 '25: -579.1K Q1 '26: -456.4K Q2 '26: -929.7K Q1 '13 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue Quarterly

0 35K 70K 105K Q1 '14: 0 Q1 '15: 0 Q2 '17: 59.1K Q3 '17: 97K Q2 '18: 0 Q3 '18: 0 Q1 '14 Q1 '15 Q2 '17 Q3 '17 Q2 '18 Q3 '18

Operating Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q4 '11: -1.8K Q1 '12: 3.2K Q2 '12: -13.3K Q3 '12: -1.1K Q1 '13: -942.3K Q2 '13: 17.2K Q2 '13: -839.8K Q3 '13: 250.4K Q3 '13: -2.3M Q4 '13: -173.1K Q4 '13: -2M Q1 '14: -4.1M Q2 '14: -3.2M Q3 '14: -2.7M Q4 '14: -2.7M Q1 '15: -2M Q2 '15: -193.6K Q3 '15: -2M Q4 '15: -1.1M Q1 '16: -1.8M Q2 '16: -1.4M Q3 '16: -1M Q4 '16: -4.6M Q1 '17: 280.8K Q2 '17: -2M Q3 '17: -1.6M Q4 '17: 4.8M Q1 '18: -1.7M Q2 '18: -2.1M Q3 '18: -1.7M Q4 '18: -1M Q1 '19: -1.3M Q2 '19: -1.1M Q3 '19: -2.4M Q4 '19: -1.7M Q1 '20: -1M Q2 '20: -1.3M Q3 '20: -1M Q4 '20: -953.7K Q1 '21: -1.5M Q2 '21: -726.8K Q3 '21: -1M Q4 '21: -1.5M Q1 '22: -2.1M Q2 '22: -728.9K Q3 '22: -1.1M Q4 '22: -750.9K Q1 '23: -1.1M Q2 '23: -1.3M Q3 '23: -949.6K Q4 '23: -793K Q1 '24: -1.2M Q2 '24: -525.1K Q3 '24: -459K Q4 '24: -674K Q1 '25: -1M Q2 '25: -383.8K Q3 '25: -658.2K Q4 '25: -242.7K Q1 '26: -536.4K Q2 '26: -875.5K Q1 '13 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q2 '12: -13.3K Q1 '13: -946.4K Q2 '13: 17.2K Q2 '13: -845.6K Q3 '13: 250.4K Q3 '13: -2.3M Q4 '13: -385.6K Q4 '13: -2.1M Q1 '14: -4.1M Q2 '14: -3.2M Q3 '14: -2.7M Q4 '14: -2.7M Q1 '15: -2M Q2 '15: -195.2K Q3 '15: -2M Q4 '15: -1.1M Q1 '16: -1.8M Q2 '16: -1.4M Q3 '16: -1M Q4 '16: -4.6M Q1 '17: 275.4K Q2 '17: -2M Q3 '17: -1.6M Q4 '17: 4.8M Q1 '18: -1.7M Q2 '18: -2.1M Q3 '18: -1.7M Q4 '18: -1M Q2 '13 Q4 '13 Q4 '14 Q4 '15 Q4 '16 Q4 '17 Q4 '18

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q4 '11: 10M Q1 '12: 100M Q2 '12: 121.3M Q4 '12: 13.5M Q1 '13: 135M Q2 '13: 135M Q4 '13: 135M Q2 '21: 8.7M Q3 '21: 10.2M Q1 '22: 13.4M Q2 '22: 1.4M Q3 '22: 1.4M Q1 '23: 1.5M Q2 '23: 1.5M Q3 '23: 1.5M Q1 '24: 1.5M Q2 '24: 1.5M Q3 '24: 1.5M Q1 '25: 1.5M Q2 '25: 1.5M Q3 '25: 1.5M Q1 '26: 2.3M Q2 '26: 2.3M Q1 '12 Q1 '13 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 -10.00 -5.00 0.00 5.00 10.00 15.00 Q3 '12: -0.01 Q4 '12: -0.01 Q1 '13: -0.01 Q3 '14: -0.10 Q4 '14: -0.11 Q1 '15: -0.10 Q2 '15: -0.35 Q3 '15: -1.59 Q4 '15: -2.41 Q1 '16: -3.17 Q2 '16: -9.02 Q3 '16: -8.04 Q4 '16: -7.84 Q1 '17: -7.40 Q2 '17: -1.62 Q3 '17: -1.60 Q4 '17: -0.41 Q1 '18: -0.28 Q2 '18: -2.72 Q3 '18: -4.77 Q4 '18: -7.38 Q1 '19: -13.62 Q2 '19: -12.40 Q3 '19: -12.76 Q4 '19: -6.33 Q1 '20: -0.07 Q2 '20: 1.34 Q3 '20: 2.81 Q4 '20: -1.69 Q1 '21: -1.65 Q2 '21: -1.63 Q3 '21: -0.56 Q4 '21: -0.55 Q1 '22: -0.52 Q2 '22: -2.29 Q3 '22: -2.72 Q4 '22: -3.55 Q1 '23: -3.99 Q2 '23: -2.78 Q3 '23: -2.91 Q4 '23: -2.71 Q1 '24: -2.93 Q2 '24: -3.07 Q3 '24: -2.66 Q4 '24: -2.57 Q1 '25: -2.38 Q2 '25: -2.00 Q3 '25: -2.05 Q4 '25: -1.59 Q1 '26: -1.20 Q2 '26: -1.16 Q4 '12 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.